148 related articles for article (PubMed ID: 35318644)
1. Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma.
Kurtansky NR; Manci RN; Bello DM; Adamson AS; Shoushtari AN; Wehner MR; Ariyan CE; Marghoob AA; Marchetti MA; Rotemberg V
Br J Dermatol; 2022 Sep; 187(3):430-432. PubMed ID: 35318644
[No Abstract] [Full Text] [Related]
2. Clinicoprognostic characteristics of cutaneous metastatic melanoma: a retrospective comparative study between acral and nonacral melanoma.
Kang HJ; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Int J Dermatol; 2020 Oct; 59(10):1249-1257. PubMed ID: 32720336
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
4. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
5. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
6. Acral melanoma: clinical advances and hope for the future.
Perez MC; Messina JL; Karapetyan L; Neves RI; Sondak VK
Clin Adv Hematol Oncol; 2023 Aug; 21(8):400-409. PubMed ID: 37530614
[TBL] [Abstract][Full Text] [Related]
7. Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.
Li J; Smalley I; Chen Z; Wu JY; Phadke MS; Teer JK; Nguyen T; Karreth FA; Koomen JM; Sarnaik AA; Zager JS; Khushalani NI; Tarhini AA; Sondak VK; Rodriguez PC; Messina JL; Chen YA; Smalley KSM
Clin Cancer Res; 2022 May; 28(10):2131-2146. PubMed ID: 35247927
[TBL] [Abstract][Full Text] [Related]
8. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 pandemic on health equality in malignant melanoma diagnosis.
Lun LK; Cheng H; Hussain R
Clin Med (Lond); 2023 Nov; 23(Suppl 6):62. PubMed ID: 38182253
[No Abstract] [Full Text] [Related]
10. Clinicopathologic features, delayed diagnosis, and survival in amelanotic acral melanoma: A comparative study with pigmented melanoma.
Wu Q; Pan J; Lin W; Zhao S; Chen M; Lu L; Chen X; Su J
J Am Acad Dermatol; 2024 Feb; 90(2):369-372. PubMed ID: 37690705
[No Abstract] [Full Text] [Related]
11. Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management.
Desai A; Ugorji R; Khachemoune A
Clin Exp Dermatol; 2018 Mar; 43(2):117-123. PubMed ID: 29235153
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Michielin O; van Akkooi ACJ; Ascierto PA; Dummer R; Keilholz U;
Ann Oncol; 2019 Dec; 30(12):1884-1901. PubMed ID: 31566661
[No Abstract] [Full Text] [Related]
13. Diagnostic Accuracy and Safety of Teledermoscopy for Cutaneous Melanoma Triage in Northern Sweden.
Zazo V; Boman A; Andersson N
Acta Derm Venereol; 2024 Feb; 104():adv15302. PubMed ID: 38323499
[No Abstract] [Full Text] [Related]
14. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous involvement in multiple myeloma mimicking acral-lentiginous melanoma.
Martorell A; Millan-Parrilla F; Gimeno-Carpio E
J Am Acad Dermatol; 2010 Jun; 62(6):1076-8. PubMed ID: 20466190
[No Abstract] [Full Text] [Related]
16. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.
Darmawan CC; Jo G; Montenegro SE; Kwak Y; Cheol L; Cho KH; Mun JH
J Am Acad Dermatol; 2019 Sep; 81(3):805-812. PubMed ID: 30731177
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous malignant melanoma: classification and clinical diagnosis.
Porras BH; Cockerell CJ
Semin Cutan Med Surg; 1997 Jun; 16(2):88-96. PubMed ID: 9220547
[TBL] [Abstract][Full Text] [Related]
18. Metastatic acral melanoma treatment outcomes: a systematic review and meta-analysis.
Cho KK; Cust AE; Foo YM; Long GV; Menzies AM; Eslick GD
Melanoma Res; 2021 Oct; 31(5):482-486. PubMed ID: 34433196
[TBL] [Abstract][Full Text] [Related]
19. Differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
Wei AH; Fane LS; Tripathi R; Bordeaux JS
J Am Acad Dermatol; 2024 Feb; 90(2):380-382. PubMed ID: 37769905
[No Abstract] [Full Text] [Related]
20. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
